GSK3B and amyotrophic lateral sclerosis: Furthermore, when increased activity and/or upregulation of GSK-3β expression was restored in Drosophila [5,14,15] and murine [16,17,18,19] models of ALS, with the treatment of different GSK-3β inhibitors, it was observed a delay in the onset of symptoms, improving motor function and slowing diseases progression.